CloudMD Creates Chairman’s Expert Advisory Board to Guide Global Growth Initiatives

World-class thought leaders in healthcare, technology, M&A, and academia bring expert knowledge of governance, strategy, growth, and value creation

VANCOUVER, British Columbia, Sept. 16, 2020 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a telehealth company revolutionizing the delivery of healthcare to patients, is pleased to announce that it has appointed experienced industry leaders to its newly formed Chairman’s Advisory Board, all with records of building successful high growth organizations with an international outlook. The members have agreed to share their experience and knowledge in creating and managing significant strategic initiatives that deliver significant value creation.

The additions to the Chairman’s Advisory Board include veterans of the technology and healthcare sectors with focus that included corporate strategy and M&A transactions. The group includes leading executives that have scaled billion-dollar businesses, led significant financing transactions on behalf of public shareholders, steered mega mergers and acquisitions, and have developed world-renowned healthcare and business academic programs.

Together with Chairman, Mark Kohler, the advisory board will provide requested assistance on a periodic basis on governance, corporate growth strategy, along with input to our ongoing M&A transactions program. The strategic advisory board was created to help position CloudMD for greater North American and international growth and to reinforce the Company’s position as a dominant healthcare leader in the space. CloudMD is focused on providing patient centric, continuity of care and whole person healthcare delivery and will use this same strategy to expand globally. The advisory board will play a crucial role in providing leading industry advice across healthcare and data privacy, building and scaling businesses, and setting the framework for transformational M&A activity.

The newly appointed members to the Chairman’s Advisory Board include:

Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship, Academic Chair of the World Health Innovation Network (WIN) and Scientific Director and CEO of the Supply Chain Advancement Network in Health (SCAN Health), a Network of Centres of Excellence and International Knowledge Translation Platform headquartered at the University of Windsor’s Odette School of Business. SCAN Health currently engages over 100 partners across 9 countries worldwide that represent health systems, government, and industry.